SciELO - Scientific Electronic Library Online

 
vol.14 issue6A Revista Portuguesa de Pneumologia no Science Citation IndexPrevalence of asthma and rhinitis in 13 year old adolescents in Porto, Portugal author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Portuguesa de Pneumologia

Print version ISSN 0873-2159

Rev Port Pneumol vol.14 no.6 Lisboa Dec. 2008

 

Estudo de polimorfismos genéticos do HLA (classes I e II) e do TNF-á em doentes com sarcoidose

 

António Morais 1

Helena Alves 2

Bruno Lima 2

Luís Delgado 3

Ricardo Gonçalves 2

Sandra Tafulo 2

 

 

Resumo

Introdução: A susceptibilidade genética na ocorrência da sarcoidose é sugerida por alguns factores, nomeadamente pela observação de casos de agregação familiar e a associação da raça a diferentes tipos de incidência e gravidade da doença. Vários estudos têm evidenciado a associação da classe I e especialmente da classe II do sistema HLA com a susceptibilidade à sarcoidose.

Objectivos: Estudo dos polimorfismos genéticos da classe I e II do sistema HLA e do TNF -á num grupo de doentes com sarcoidose, nomeadamente a sua influência na susceptibilidade, apresentação clínica e evolução da doença.

Material e métodos: Foram incluídos 104 doentes com sarcoidose, tendo sido estudadas a apresentação clínica, funcional, radiológica e os resultados do LBA. Foram usados métodos de biologia molecular na genotipagem do HLA -A*, B*, C*, DRB1*, DQB1* e TNF -á. O ADN foi extraído do sangue periférico e foram usados os métodos PCR -SSP e PCR -reverse hibridization. As frequências alélicas foram comparadas com controlos da mesma região geográfica pelo teste ÷2, sendo usado o teste Kruskal -Wallis para variáveis contínuas.

Resultados: Comparativamente com os controlos, os doentes incluídos apresentavam frequências aumentadas de: B*08 (10,6% vs 6,1%), OR=1,8, IC=[1,1;3,1], p=0,02; DRB1*12 (4,3% vs 1,7%), OR=2,63, IC=[1,1;6,1], p=0,03. Os doentes com eritema nodoso apresentaram aumento das frequências alélicas de DRB1*03 (28% vs 9,3%), RR=2,39, IC=[1,5;3,8], pc=0,01 e DQB1*02 (38% vs 18%), RR=2,1, IC=[1,3;3,3], pc=0,02. O alelo DQB1*03 está diminuído nos doentes que apresentam síndroma ventilatória obstrutiva, RR=0,53, IC=[0,3;0,9],pc=0,05. O alelo DRB1*15 encontra -se significativamente associado quer à síndroma ventilatória restritiva quer à diminuição da transferência alveolocapilar (21,1% vs 6,6%), RR=2,46, IC=[1,35;4,48], p=0,01 e (18,1% vs 3,8%), RR=1,87, pc=0,05, respectivamente. Por sua vez, o genótipo A/A (high) do TNF -á apresentou uma frequência aumentada (p=0,04) nos doentes com eritema nodoso.

Conclusões: Os resultados obtidos adicionam evidência ao facto de, quer a classe I quer a classe II do sistema HLA influenciarem a susceptibilidade, o tipo de apresentação, o grau de gravidade e a evolução na sarcoidose. Por outro lado, o eritema nodoso parece relacionar -se com o genótipo de elevada produção de TNF -á, associação esta já anteriormente descrita.

Palavras-chave: Sacordoise, genética, HLA.

 

 

HLA class I and II and TNF-á gene polymorphisms in sarcoidosis patients

Abstract

Introduction: Several factors suggest a genetic predisposition to sarcoidosis, namely the recognition of race as a risk factor and the occurrence of familial clustering of cases. Several studies have reported an association of sarcoidosis and HLA class I and especially class II alleles in different populations.

Aim: HLA class I, class II and TNF-á genotyping in a group of sarcoidosis patients and its relation with clinical presentation and outcome.

Material and methods: A total of 104 sarcoidosis patients were included. Clinical presentation, functional, radiology, BAL findings and organ involvement were studied. HLA– A*, -B*, -C*, DRB1*, DQB1* and TNF-á were genotyped by molecular biology methods. DNA was extracted from peripheral blood and PCR-SSP and PCR-reverse hybridisation methods were used. Allele frequencies were compared with controls from the same region. The X2 test was used for discrete values and the Kruskal-Wallis test for continuous values.

Results: When patients were compared with controls we noticed increased frequencies of B*08 (10.6% vs. 6.1%), O.R.=1.8, C.I.=[1.1;3.1], p=0.02; DRB1*12 (4.3% vs. 1.7%), O.R.=2.63, C.I.=[1.1;6.1], p=0.03. Patients with erythema nodosum have increased frequencies of the alleles DRB1*03 (28% vs. 9.3%), R.R.=2.39, C.I.=[1.5;3.8], pc=0.01 and DQB1*02 (38% vs. 18%), R.R.=2.1, C.I.=[1.3;3.3], pc=0.02. Allele DQB1*03 is decreased in patients with obstructive pattern R.R.=0.53, C.I.=[0.3;0.9], pc=0.05. Allele DRB1*15 is related to restrictive pattern and reduced diffusion capacity (21.1% vs. 6.6%), R.R.=2.46, C.I.=[1.35;4.48], p=0.01 and (18.1% vs. 3.8%), R.R.=1.87, pc= 0.05 respectively. The TNF-á A/A (high) genotype is significantly associated with erythema nodosum (p=0.04).

Conclusions: These data add support to the genetic association of HLA class I and II with sarcoidosis in terms of susceptibility, type of presentation, severity and outcome. Moreover as previously described in other populations, the TNF-á A/A (high) genotype has a significant association with erythema nodosum.

Key-words: Sarcoidosis, genetics, HLA.

 

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

 

Bibliografia / Bibliography

1. Hunninghake GW, Costabel U, Ando M. ATS/ERS/WASOG Statement on Sarcoidosis. Am J Respir Crit Care Med 1999; 160:736 -55.        [ Links ]

2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153 -65.

3. Baughman RP, Lower EE, du Bois R. Sarcoidosis. Lancet 2003; 361: 1111.

4. Iannuzzi MC, Rybicki BA. Genetics ofn sarcoidosis; candidate genes and genome scans. Proc Am Thorac Soc 2007; (4):108 -16.

5. Rybicki BA, Iannuzzi MC, Frederick MM et al. Familial aggregation of sarcoidosis. A case control etiologic study of sarcoidosis (ACCESS). Am J Repir Crit Care Med 2001; 164: 2085.

6. Klein J, Sato A. The HLA System. N Engl J Med, 2000; 343, 10: 702 -709

7. Rybicki BA, Iannuzzi MC. Sarcoidosis and human leucocyte antigen class I and II genes. Am J Respir Crit Care Med 2004; 169: 665 -666.

8. Brewerton D, Cockburn C, James D, et al. HLA antigens in sarcoidosis. Clin Exp Immunol 1977 ; 27 : 227-229.

9. Olenchock S, Heise E, Marz J, et al. HLA -B8 in sarcoidosis. Ann Allergy 1981 ; 47 : 151 -153.

10. Lenhart K, Kolek V, Bartova A. HLA antigens associated with sarcoidosis. Dis Markers 1990 ; 8 : 23 -29.

11. Dubaniewicz A, Szczerkowska Z. HLA -A,B,C antigens in pulmonary sarcoidosis in Polish population. Arch Immunol Ther Exp (Warz) 1999; 47 (1): 55 -9.

12. Pasturenzi L, Martinetti M, Cuccia M. HLA class I, II, III polymorphism in Italian patients with sarcoidosis. Chest 1993 Oct; 104 (4): 1170 -5.

13. Martinetti M, Tinelli C, Kolek V, et al. ‘The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152:557 -64.

14. Sharma S, Balamurugan A, Pandey R, et al. Human leukocyte antigen – DR alleles influence the clinical course of pulmonary sarcoidosis in asian Indians. Am J Respir Cell Mol Biol 2003; 29: 225 -31.

15. Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin Proc 2003; 78(4):436 -42.

16. McIntyre J, Mckee K, Loadholt C, et al. Increased HLA-B7 antigen frequency in South Caroline blacks in association with sarcoidosis. Transplant Proc 1977; 9: 173 -176.

17. Rutherford RM, Brutshe MH, Kearns M, et al. HLA -DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21(3):191 -8.

18. Smith M, Turton C, Mitchell D, et al. Association of HLA -B8 with spontaneous resolution in sarcoidosis. Thorax 1981; 36: 296 -298.

19. Grunewald J, Eklund A, Olerup O. Human luekocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696 -702.

20. Ishihara M, Inoko H, Suzuki K, et al. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-   -RFLP. Jpn J Ophthalmol 1996; 40: 540 -3.

21. Ishihara M, Ishida T, Inoko H, et al. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn J Ophthalmol 1996; 40: 86 -94.

22. Nowack D, Goebel KM. Genetic aspects of sarcoidosis. ClassII histocompatibility antigens and a family study. Arch Intern Med 1987; 147: 481 -3.

23. Rossman MD, Thomson B, Frederick M, et al. HLA -DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720 -35.

24. Iannuzzi M, Maliarik M, Poisson L, et al. Sarcoidosis susceptibility and resistance HLA -DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003; 1670:1225 -31.

25. Grutters J, Sato H, Welsh K, et al. Am J Respir Cell Mol Biol 2003; 29:S59 -S62.

26. Voorter CE, Drent M, Van den Berger -Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA -DQB1*0602 -DRB1*150101. Hum Immunol 2005; 66(7):826 -35.

27. Rybicki BA, Maliarik MJ, Poisson LM. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 2003; 167: 444 -449.

28. Sato H, Grutters J, Pantelidis P. et al. HLA – DQB1*0201: a marker for good prognosis in british and dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27:406 -11.

29. Grutters JC, Ruven HJT, Sato H, et al. MHC haplotype analysis in Dutch sarcoidosis patients presenting with Löfgren’s syndrome. In: Grutters JC (Ed.). Genetic polymorphisms and phenotypes in sarcoidosis. Utrecht, Thesis University Utrech, 2003: 85 -96.

30. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumor necrosis factor -alpha, lymphotoxin -alpha and HLA -DRB1 gene polymorphisms with Lofgren’s syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65(2):163 -71.

31. Berlin M, Fogdell -Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601 -5.

32. Grutters JC, Sato H, Pantelidis P, et al. Analysis of IL -6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vas Diffuse Lung Dis 2003; 20(1):20 -7.

33. Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clinics in Dermatology 2007; 25:242 -9.

34. Somoskovi A, Zissel G, Seitzer U, et al. Polymorphisms at position – 308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide –induced TNF -alpha release in sarcoidosis. Cytokine 1999; 11 (11): 882 -887.

35. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor--857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119--1124.

36. Grutters JC, Ruven HJT, Sato H, et al. TNF promotor haplotypes associate with clinical phenotypes and prognosis in sarcoidosis. In: Grutters JC (Ed.). Genetic polymorphisms and phenotypes in sarcoidosis. Utrecht, Thesis University Utrecht; 2003: 49 -66.

37. Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V, Welsh KI, Vacha J, du Bois RM, Petrek M. Association of tumor necrosis factor -á, lymphotoxin-á and DRB1 gene polymorphisms with Löfgren’s syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65:163 -717

38. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promotor gene polymorphism in sarcoidosis. Cytokine 1997; 9: 787 -90.

39. Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19.

40. Labunski S, Posern G, Ludwig S, et al. Tumour necrosis factor -alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81(1): 18--21.

41. Yamaguchi E, Itoh A, Hizawa N, et al. The gene polymorphism of tumour necrosis factor -beta, but not that of tumour necrosis factor -alpha, is associated with prognosis of sarcoidosis. Chest 2001; 119 (3): 753-61.

42. Takashigue N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54(2):191-3.

 

1 Serviço de Pneumologia do Hospital São João, Porto / Pulmonology Unit, Hospital São João, Porto

2 Centro de Histocompatibilidade do Norte / Histocompatability Centre of the North

3 Serviço de Imunologia da Faculdade de Medicina do Porto / Pulmonology Unit, Porto Faculty of Medicine